14.8K
Downloads
77
Episodes
Authentic conversations about the knowledge gaps in ophthalmology and eye care, with guests hailing from ophthalmology and optometry clinics, vision research labs, industry, private companies, and the low vision community.
Episodes
Monday Dec 06, 2021
Monday Dec 06, 2021
Jay Newman, Head of U.S. Commercial at Spark Therapeutics provides a detailed overview of gene therapy for inherited retinal disease. Jay discusses the challenges associated with gaining regulatory approval and how this approval has impacted the company and the low vision community at large.
Comments (0)
To leave or reply to comments, please download free Podbean or
No Comments
To leave or reply to comments,
please download free Podbean App.